TITLE:
Obese Patients With or Without Comorbidities (RIO-North America)

CONDITION:
Obesity

INTERVENTION:
Rimonabant (SR141716)

SUMMARY:

      To assess the effects of weight loss and weight maintenance over a period of two years when
      prescribed with a hypocaloric diet in obese patients with or without comorbidities
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        -  Stable weight (variation of less than 5 kg within 3 months prior to screening visit)

          -  BMI (Body Mass Index) of 30 or greater in patients with or without comorbidities, or
             BMI greater than 27 in patients with treated or untreated hypertension and/or treated
             or untreated dyslipidemia
      
